The Implementation of Rifapentine and Isoniazid (3HP) in two Remote Arctic Communities with a Predominantly Inuit Population, the Taima TB 3HP Study
Articles » Scholarly, peer reviewed
Author/Creator
G. G. Alvarez
D. Van Dyk
R. Mallick
S. Lesperance
P. Demaio ... [et al.]
International Journal of Circumpolar Health, vol. 79, no. 1, Article: 1758501, May 7, 2020
Description
Study of 247 participants in Nunavut examines the feasibility and safety profile of 3HP for the treatment of Latent Tuberculosis Infection (LTBI).